These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3749491)

  • 1. A biological approach to breast cancer.
    Wall P
    Radiography; 1986; 52(603):125-30. PubMed ID: 3749491
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of dose-dense chemotherapy in the management of breast cancer.
    Norton L
    Clin Adv Hematol Oncol; 2006 Jan; 4(1):36-7. PubMed ID: 16562368
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience with other tumors: breast, ovary, brain tumors and sarcomas].
    Maraninchi D; Droz JP
    Bull Cancer; 1995; 82 Suppl 1():66s-72s. PubMed ID: 7626857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of cancer of the breast in the metastatic phase].
    Clavel M
    Pathol Biol (Paris); 1989 Feb; 37(2):137-9. PubMed ID: 2652064
    [No Abstract]   [Full Text] [Related]  

  • 5. Breast cancer 1984: state of the art.
    Sledge GW
    Indiana Med; 1984 Dec; 77(12):935-9. PubMed ID: 6394645
    [No Abstract]   [Full Text] [Related]  

  • 6. [Principles of adjuvant drug therapy in breast cancer].
    Castiglione M; Schnürch HG; Bender HG; Goldhirsch A
    Gynakologe; 1994 Apr; 27(2):49-63. PubMed ID: 8039743
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adjuvant therapy in breast cancer].
    Semiglazov VF
    Vopr Onkol; 2000; 46(1):18-27. PubMed ID: 10789218
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on PBT-1 study of high-dose consolidation versus standard therapy in metastatic breast cancer.
    Livingston R; Crowley J
    J Clin Oncol; 1999 Nov; 17(11 Suppl):22-4. PubMed ID: 10630257
    [No Abstract]   [Full Text] [Related]  

  • 9. New advances in the management of metastatic breast cancer.
    Glück S
    J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S12-6. PubMed ID: 16280104
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of recurrent breast cancer.
    Robert NJ; Beveridge RA
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):709-19. PubMed ID: 7731643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined chemotherapy in metastatic breast cancer: predictive value of dose levels and performance status].
    Brufman G; Sulkes A; Fuks Z; Biran S
    Harefuah; 1986 Jul; 111(1-2):24-6. PubMed ID: 3781373
    [No Abstract]   [Full Text] [Related]  

  • 12. The sound and the fury: an update on the role of high-dose chemotherapy and autologous stem cell salvage for both metastatic and high-risk breast cancer.
    Bar MH
    Conn Med; 2000 Jan; 64(1):3-6. PubMed ID: 10697358
    [No Abstract]   [Full Text] [Related]  

  • 13. Adult multicenter trials using dexrazoxane to protect against cardiac toxicity.
    Swain SM
    Semin Oncol; 1998 Aug; 25(4 Suppl 10):43-7. PubMed ID: 9768823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Our experience with chemotherapeutic agents in the treatment of breast cancer.
    Bandouvas T; Koundouris C; Kaspiris A; Kallistros A; Alexandridis K; Kapellakis Z; Efthimiou E; Taggalos A
    J Chemother; 1991 Jan; 3 Suppl 1():227-30. PubMed ID: 12041772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancer.
    Awada A
    Forum (Genova); 2002; 12(1):4-15. PubMed ID: 12634907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study.
    Bengala C; Danesi R; Guarneri V; Pazzagli I; Donati S; Favre C; Fogli S; Biadi O; Innocenti F; Del Tacca M; Mariani M; Conte PF
    Bone Marrow Transplant; 2003 Feb; 31(4):275-80. PubMed ID: 12621462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: a single-institution experience with 132 consecutive patients.
    Stemmer SM; Hardan I; Raz H; Adamou AK; Inbar M; Gottfried M; Merrick Y; Cohen Y; Sulkes A; Ben-Baruch N; Pfeffer RP; Brenner HJ; Rizel S
    Bone Marrow Transplant; 2003 Apr; 31(8):655-61. PubMed ID: 12692605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of advanced breast cancer.
    Hortobagyi GN; Piccart-Gebhart MJ
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):1-5. PubMed ID: 8893891
    [No Abstract]   [Full Text] [Related]  

  • 19. [A comparative study of 4 sequential first-line chemotherapy protocols in locally advanced breast cancer].
    Ferrero JM; Namer M; Dufour JF; Largillier R; Creisson A; Teissier E; Machiavello JC; Lallement M; Monticelli J; Abbes M
    Bull Cancer; 1997 Jan; 84(1):10-6. PubMed ID: 9180853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-dose chemotherapy for metastatic breast cancer without certain advantages so far].
    Kleeberg UR
    Strahlenther Onkol; 2000 Jul; 176(7):334-5. PubMed ID: 10963001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.